Report ID: SQMIG35H2292
Report ID:
SQMIG35H2292 |
Region:
Global |
Published Date: November, 2024
Pages:
169
|
Tables:
93 |
Figures:
66
Global Live Cell Imaging Market was valued at USD 2.3 Billion in 2022 and is expected to rise from USD 2.49 Billion in 2023 to USD 4.67 Billion by 2031, at a CAGR of 8.2% during the forecast period (2024–2031).
Growing investments in the development of imaging technologies and rising demand for cell research and development are projected to bolster live cell imaging market growth over the coming years. Growing emphasis on the use of live cell imaging in oncology research and high investments in stem cell research are also projected to uplift the demand for live cell imaging in the future. Rising drug discovery and development activities around the world, supportive government funding, and rising use of cell therapies are also expected to favor live cell imaging demand outlook going forward. Use of artificial intelligence and machine learning is also projected to be key trend among live cell imaging companies looking to make a mark across the study period and beyond. However, lack of standardization, high costs, and complexity in operations are forecasted to be key constraints for market development in the long run.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2292